Mr. Speaker, I am very happy to speak to this issue, but as the member knows, committees are responsible for their own destiny and decisions. In this case, the committee clearly decided to look at the health risks and harms, and I think that is important to do. We have not done enough of that.
We have heard a lot of issues out there about medical marijuana, but we have not looked at the normalization and what the potential health risks and harms are. This study was strategically and importantly focused on something that is very important to Canadians.